The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma

详细信息    查看全文

• 作者：David J. Pinato¹ ; ^&dagger ; ; ^{david.pinato@imperial.ac.uk} ; Rohini Sharma¹ ; ^&dagger ; ; Elias Allara² ; Clarence Yen¹ ; Tadaaki Arizumi³ ; Keiichi Kubota⁴ ; Dominik Bettinger⁵ ; Jeong Won Jang⁶ ; Carlo Smirne⁷ ; Young Woon Kim⁶ ; Masatoshi Kudo³ ; Jessica Howell¹ ; Ramya Ramaswami¹ ; Michela E. Burlone⁷ ; Vito Guerra⁸ ; Robert Thimme⁵ ; Mitsuru Ishizuka⁴ ; Justin Stebbing¹ ; Mario Pirisi⁷ ; Brian I. Carr⁹
• 关键词：Prognosis ; Carcinoma ; Hepatocellular ; Liver failure ; ALBI ; Albumins ; Bilirubin ; Retrospective studies ; Biomarkers
• 刊名：Journal of Hepatology
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：66
• 期：2
• 页码：338-346
• 全文大小：759 K
• 卷排序：66

文摘

Overall survival (OS) is a composite clinical endpoint in hepatocellular carcinoma (HCC) due to the mutual influence of cirrhosis and active malignancy in dictating patient’s mortality. The ALBI grade is a recently described index of liver dysfunction in hepatocellular carcinoma, based solely on albumin and bilirubin levels. Whilst accurate, this score lacks cross-validation, especially in intermediate stage HCC, where OS is highly heterogeneous.MethodsWe evaluated the prognostic accuracy of the ALBI grade in estimating OS in a large, multi-centre study of 2426 patients, including a large proportion of intermediate stage patients treated with chemoembolization (n = 1461) accrued from Europe, the United States and Asia.ResultsAnalysis of survival by primary treatment modality confirmed the ALBI grade as a significant predictor of patient OS after surgical resection (p <0.001), transarterial chemoembolization (p <0.001) and sorafenib (p <0.001). Stratification by Barcelona Clinic Liver Cancer stage confirmed the independent prognostic value of the ALBI across the diverse stages of the disease, geographical regions of origin and time of recruitment to the study (p <0.001).ConclusionsIn this large, multi-centre retrospective study, the ALBI grade satisfied the criteria for accuracy and reproducibility following statistical validation in Eastern and Western HCC patients, including those treated with chemoembolization. Consideration should be given to the ALBI grade as a stratifying biomarker of liver reserve in routine clinical practice.Lay summaryLiver failure is a key determinant influencing the natural history of hepatocellular carcinoma (HCC). In this large multi-centre study we externally validate a novel biomarker of liver functional reserve, the ALBI grade, across all the stages of HCC.